← Browse by Condition
Medical Condition
diabetic macular edema
Total Trials
7
Recruiting Now
7
Trial Phases
Phase 2, Phase 3, Phase 1, Phase 2, Phase 3
NCT06984822
Recruiting
Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone Implant
Enrollment
150 pts
Location
Sweden
Sponsor
Vastra Gotaland Region
NCT06572553 Phase 2, Phase 3
Recruiting
Evaluation of Therapeutic Efficacy of Faricimab for Clinical AMD, DME, and RVO Patients
Enrollment
30 pts
Location
China
Sponsor
Second Affiliated Hospital, Sc...
NCT07458061 Phase 1, Phase 2
Recruiting
Kamuvudine-9 (K9) in Diabetic Macular Edema
Enrollment
10 pts
Location
United States
Sponsor
Dr. Bryan Strelow
NCT06332690
Recruiting
OCT and OCT-Angiography Biomarkers of Treatment Response to Dexamethasone Implant in Macular Edema Due to Retinal Vascular Diseases - DME and RVO
Enrollment
50 pts
Location
Italy
Sponsor
IRCCS Multimedica
NCT04935749
Recruiting
Epidemiologic Assessment of Diabetic Retinopathy in Egypt Using Ultrawide Field Fundus Photographs
Enrollment
10,000 pts
Location
Egypt
Sponsor
Alexandria University
NCT07449923 Phase 3
Recruiting
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Enrollment
240 pts
Location
United States
Sponsor
EyePoint Pharmaceuticals, Inc.
NCT06680817
Recruiting
A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study)
Enrollment
850 pts
Location
Austria, Bulgaria, C...
Sponsor
Hoffmann-La Roche